Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Research & Development: 2023-2024

Historic Research & Development for Pyxis Oncology (PYXS) over the last 2 years, with Dec 2024 value amounting to $58.7 million.

  • Pyxis Oncology's Research & Development rose 0.38% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.0 million, marking a year-over-year change of. This contributed to the annual value of $58.7 million for FY2024, which is 18.47% up from last year.
  • As of FY2024, Pyxis Oncology's Research & Development stood at $58.7 million, which was up 18.47% from $49.6 million recorded in FY2023.
  • Over the past 5 years, Pyxis Oncology's Research & Development peaked at $58.7 million during FY2024, and registered a low of $49.6 million during FY2023.
  • Over the past 2 years, Pyxis Oncology's median Research & Development value was $54.2 million (recorded in 2023), while the average stood at $54.2 million.
  • Data for Pyxis Oncology's Research & Development shows a peak YoY grew of 18.47% (in 2024) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Research & Development (Yearly) stood at $49.6 million in 2023, then climbed by 18.47% to $58.7 million in 2024.